HUTCHMED (HCM)

• Market cap: $1.88B
• 1 day: 2.15%
• 5 days: -0.73%
• 1 month: -13.89%
• 3 months: -23.11%
• 6 months: -18.7%
• Year to date: -20.07%
• 1 year: -38.43%
• 5 years: -63.66%
• 10 years: -18.64%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Employees: 1,796